From GlobeNewswire: 2025-06-17 20:30:00

Serina Therapeutics, Inc. congratulates its partner Juvenescence Ltd. on the $76 million first tranche close of its $150 million Series B financing round, along with a new partnership with M42 in Abu Dhabi. This funding and alliance aim to accelerate Juvenescence’s mission to develop therapies for age-related diseases. Serina is proud to be part of Juvenescence’s network of science-driven enterprises. Juvenescence, a clinical-stage biotech company, focuses on extending healthy lifespan through medicines targeting aging mechanisms. M42, a global health champion, utilizes AI and technology to advance healthcare innovation for people and the planet, with over 480 facilities in 26 countries.



Read more at GlobeNewswire: UPDATED: Serina Therapeutics Congratulates Juvenescence